Annual CFI
-$532.00 K
-$265.00 K-99.25%
December 31, 2024
Summary
- As of March 9, 2025, JSPR annual cash flow from investing activities is -$532.00 thousand, with the most recent change of -$265.00 thousand (-99.25%) on December 31, 2024.
- During the last 3 years, JSPR annual CFI has risen by +$1.90 million (+78.09%).
Performance
JSPR Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFI
-$76.00 K
+$198.00 K+72.26%
December 31, 2024
Summary
- As of March 9, 2025, JSPR quarterly cash flow from investing activities is -$76.00 thousand, with the most recent change of +$198.00 thousand (+72.26%) on December 31, 2024.
- Over the past year, JSPR quarterly CFI has increased by +$198.00 thousand (+72.26%).
Performance
JSPR Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFI
-$532.00 K
+$154.00 K+22.45%
December 31, 2024
Summary
- As of March 9, 2025, JSPR TTM cash flow from investing activities is -$532.00 thousand, with the most recent change of +$154.00 thousand (+22.45%) on December 31, 2024.
- Over the past year, JSPR TTM CFI has increased by +$154.00 thousand (+22.45%).
- JSPR TTM CFI is now -347.06% below its all-time high of -$119.00 thousand, reached on September 30, 2023.
Performance
JSPR TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
JSPR Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -99.3% | +72.3% | +22.4% |
| 3 y3 years | +78.1% | -100.0% | -347.1% |
| 5 y5 years | -100.0% | -100.0% | -347.1% |
JSPR Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -99.3% | +78.1% | <-9999.0% | +89.3% | -347.1% | +78.1% |
| 5 y | 5-year | <-9999.0% | +78.1% | <-9999.0% | +92.1% | -347.1% | +78.1% |
| alltime | all time | <-9999.0% | +78.1% | <-9999.0% | +92.1% | -347.1% | +78.1% |
Jasper Therapeutics Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | -$532.00 K(+99.3%) | -$76.00 K(-72.3%) | -$532.00 K(-22.4%) |
| Sep 2024 | - | -$274.00 K(+74.5%) | -$686.00 K(+66.5%) |
| Jun 2024 | - | -$157.00 K(+528.0%) | -$412.00 K(+54.9%) |
| Mar 2024 | - | -$25.00 K(-89.1%) | -$266.00 K(-0.4%) |
| Dec 2023 | -$267.00 K(-53.6%) | -$230.00 K(<-9900.0%) | -$267.00 K(+124.4%) |
| Sep 2023 | - | $0.00(-100.0%) | -$119.00 K(-65.1%) |
| Jun 2023 | - | -$11.00 K(-57.7%) | -$341.00 K(-40.5%) |
| Mar 2023 | - | -$26.00 K(-68.3%) | -$573.00 K(-0.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2022 | -$576.00 K(-76.3%) | -$82.00 K(-63.1%) | -$576.00 K(-52.2%) |
| Sep 2022 | - | -$222.00 K(-8.6%) | -$1.21 M(-17.1%) |
| Jun 2022 | - | -$243.00 K(+737.9%) | -$1.45 M(-2.9%) |
| Mar 2022 | - | -$29.00 K(-95.9%) | -$1.50 M(-38.3%) |
| Dec 2021 | -$2.43 M(<-9900.0%) | -$711.00 K(+51.3%) | -$2.43 M(+41.4%) |
| Sep 2021 | - | -$470.00 K(+63.8%) | -$1.72 M(+37.7%) |
| Jun 2021 | - | -$287.00 K(-70.1%) | -$1.25 M(+29.9%) |
| Mar 2021 | - | -$960.00 K | -$960.00 K |
| Dec 2020 | $0.00 | - | - |
FAQ
- What is Jasper Therapeutics annual cash flow from investing activities?
- What is the all time high annual CFI for Jasper Therapeutics?
- What is Jasper Therapeutics annual CFI year-on-year change?
- What is Jasper Therapeutics quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Jasper Therapeutics?
- What is Jasper Therapeutics quarterly CFI year-on-year change?
- What is Jasper Therapeutics TTM cash flow from investing activities?
- What is the all time high TTM CFI for Jasper Therapeutics?
- What is Jasper Therapeutics TTM CFI year-on-year change?
What is Jasper Therapeutics annual cash flow from investing activities?
The current annual CFI of JSPR is -$532.00 K
What is the all time high annual CFI for Jasper Therapeutics?
Jasper Therapeutics all-time high annual cash flow from investing activities is $0.00
What is Jasper Therapeutics annual CFI year-on-year change?
Over the past year, JSPR annual cash flow from investing activities has changed by -$265.00 K (-99.25%)
What is Jasper Therapeutics quarterly cash flow from investing activities?
The current quarterly CFI of JSPR is -$76.00 K
What is the all time high quarterly CFI for Jasper Therapeutics?
Jasper Therapeutics all-time high quarterly cash flow from investing activities is $0.00
What is Jasper Therapeutics quarterly CFI year-on-year change?
Over the past year, JSPR quarterly cash flow from investing activities has changed by +$198.00 K (+72.26%)
What is Jasper Therapeutics TTM cash flow from investing activities?
The current TTM CFI of JSPR is -$532.00 K
What is the all time high TTM CFI for Jasper Therapeutics?
Jasper Therapeutics all-time high TTM cash flow from investing activities is -$119.00 K
What is Jasper Therapeutics TTM CFI year-on-year change?
Over the past year, JSPR TTM cash flow from investing activities has changed by +$154.00 K (+22.45%)